AMRI announced Michael Mulhern has joined the company as chief executive officer, succeeding William S. Marth. Mulhern was previously chief executive officer of Sterigenics International, a global provider of contract sterilization, gamma technologies and medical isotopes. Mr. Marth will remain with the company in an advisory role. AMRI is a portfolio company of The Carlyle Group and GTCR.
“Michael is a highly accomplished executive with a 30-year track record of value creation in the healthcare and distribution sectors,” Stephen H. Wise, managing director and global head of healthcare for Carlyle, said. “His role as a member of AMRI’s board of directors, coupled with his experience leading three private equity-backed companies, will make this a smooth transition.”
Since 2002, Mulhern has been CEO of three companies backed by GTCR – Sterigenics International, Fairmont Food Group, and American Sanitary – where he established a track record of product development, operational excellence, quality customer service and global growth. He previously held roles at Baxter International and Alliant Foodservice. Mulhern earned his B.A. in economics from Pennsylvania State University.
“I am excited to join AMRI and look forward to working with such a talented group of professionals around the world to make a great company even better,” Mulhern said. “I believe a cohesive, integrated AMRI will better enable us to serve our global customers. Bill and his team have accomplished great things, and I look forward to leading AMRI through its next phase of growth.”